MPS Pharmaa

MPS_Pharmaa22 Apr 2024

Pharmaceuticals

₹

0.00 (0.00%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in MPS Pharmaa

MPS Pharmaa

Pharmaceuticals

MPS_Pharmaa22 Apr 2024

₹

0.00 (0.00%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
14-Mar-2024	BC	ADVIK LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/03/2024 inter alia to consider and approve Dear Sir Pursuant to Regulation 25(3)	26-Mar-2024
01-Feb-2024	BC	ADVIK LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2024 inter alia to consider and approve the Un-audited Financial Results of the	13-Feb-2024
30-Oct-2023	BC	ADVIK LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2023 inter alia to consider and approve Pursuant to Regulation 29 of the Securi	09-Nov-2023
29-Aug-2023	BC	Pursuant to Regulation 30 read with Schedule III of the SEBI (LODR) Regulations, 2015 , we wish to inform you that Board of Directors in its meeting held today i.e. on Tuesday, 29th August, 2023 at 0	29-Sep-2023
29-Aug-2023	BC	Pursuant to Regulation 30 read with Schedule III of the SEBI (LODR) Regulations, 2015 , we wish to inform you that Board of Directors in its meeting held today i.e. on Tuesday, 29th August, 2023 at 0	23-Sep-2023

No Rights has been declared by MPS_Pharmaa

Book Closure

Record Date	Split Date	Purpose
26-Mar-2024	-	ADVIK LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/03/2024 inter alia to consider and approve Dear Sir Pursuant to Regulation 25(3)
13-Feb-2024	-	ADVIK LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2024 inter alia to consider and approve the Un-audited Financial Results of the
09-Nov-2023	-	ADVIK LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2023 inter alia to consider and approve Pursuant to Regulation 29 of the Securi
29-Sep-2023	-	Pursuant to Regulation 30 read with Schedule III of the SEBI (LODR) Regulations, 2015 , we wish to inform you that Board of Directors in its meeting held today i.e. on Tuesday, 29th August, 2023 at 0
23-Sep-2023	01 Jan'1900	Pursuant to Regulation 30 read with Schedule III of the SEBI (LODR) Regulations, 2015 , we wish to inform you that Board of Directors in its meeting held today i.e. on Tuesday, 29th August, 2023 at 0

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
MPS Pharmaa Ltd ₹3.21(0.00/0.00%)	3.21	+0.00	6.13	52.86	0.00	2.53
Astrazeneca Pharma India Ltd ₹5,415.40(+81.55/1.53%)	5,415.40	+81.55	13,538.50	71.09	84.88	20.67
Bliss GVS Pharma Ltd ₹122.60(+5.85/5.01%)	122.60	+5.85	1,283.51	60.79	18.80	1.31
Cipla Ltd ₹1,409.40(+4.00/0.28%)	1,409.40	+4.00	113,794.25	54.54	34.60	4.40
Abbott India Ltd ₹25,864.85(+201.35/0.78%)	25,864.85	+201.35	54,962.81	15.87	47.98	17.68
Amrutanjan Health Care Ltd ₹680.85(-8.80/-1.28%)	680.85	-8.80	1,968.38	13.21	44.73	7.51

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	0.00	0.00	0.00	0.00	0.00	0.00
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	0.00	0.00	0.00	0.00	0.00	0.00
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.00	0.06	0.03	0.02	0.00	0.00
Total Income	0.00	0.06	0.03	0.02	0.00	0.00
Total Expenditure	0.18	0.21	0.19	0.31	0.23	0.24
PBIDT	-0.18	-0.15	-0.16	-0.29	-0.23	-0.24
Interest	0.00	0.00	0.00	0.00	0.00	0.00
PBDT	-0.18	-0.15	-0.16	-0.29	-0.23	-0.24
Depreciation	0.04	0.04	0.04	0.04	0.04	0.04
Tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-0.01	-0.01	-0.01	-0.01	0.00	0.00
Reported Profit After Tax	-0.21	-0.18	-0.19	-0.32	-0.26	-0.27
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	-0.21	-0.18	-0.19	-0.32	-0.26	-0.27

EPS (Unit Curr.)	-0.11	-0.10	-0.10	-0.16	-0.14	-0.14
EPS (Adj) (Unit Curr.)	-0.11	-0.10	-0.10	-0.16	-0.14	-0.14
Calculated EPS (Unit Curr.)	-0.11	-0.10	-0.10	-0.16	-0.14	-0.14
Calculated EPS (Adj) (Unit Curr.)	-0.11	-0.10	-0.10	-0.16	-0.14	-0.14
Calculated EPS (Ann.) (Unit Curr.)	-0.45	-0.39	-0.39	-0.66	-0.54	-0.57
Calculated EPS (Adj) (Ann.) (Unit Curr.)	-0.45	-0.39	-0.39	-0.66	-0.54	-0.57
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	19.11	19.11	19.11	19.11	19.11	19.11
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	0.00	0.00	0.00	0.00	0.00	0.00
PBDTM(%)	0.00	0.00	0.00	0.00	0.00	0.00
PATM(%)	0.00	0.00	0.00	0.00	0.00	0.00

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	19.11	19.11	19.11	19.11	19.11	19.11
Reserves Total	-16.32	-15.29	-15.16	-10.75	-9.58	-8.35
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	2.79	3.82	3.95	8.36	9.53	10.76
Secured Loans	6.48	5.57	4.59	2.48	2.50	2.90
Unsecured Loans	0.29	0.24	1.09	0.05	0.01	0.00
Total Debt	6.77	5.81	5.68	2.53	2.51	2.90
Total Liabilities	9.56	9.63	9.63	10.89	12.04	13.66
APPLICATION OF FUNDS :
Gross Block	15.84	15.72	15.71	16.05	16.16	16.16
Less : Accumulated Depreciation	11.70	11.55	11.04	10.79	10.28	9.69
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	4.14	4.17	4.67	5.26	5.88	6.47
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	3.40	3.42	3.90	5.02	5.43	5.21
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.54	0.54	0.54	0.92	0.92	0.92
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	0.50	0.55	0.57	0.57	0.57	0.57
Sundry Debtors	0.03	0.03	0.59	2.53	2.61	3.86
Cash and Bank	0.01	0.01	0.01	0.01	0.02	0.02
Loans and Advances	1.57	1.43	1.01	2.08	2.12	2.10
Total Current Assets	2.10	2.03	2.19	5.20	5.32	6.55
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	0.41	0.27	0.98	4.76	4.72	4.62
Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Total Current Liabilities	0.41	0.27	0.98	4.76	4.72	4.62
Net Current Assets	1.70	1.76	1.21	0.44	0.60	1.93
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.42	0.42	0.06	0.05	0.04	0.04
Deferred Tax Liability	0.51	0.53	0.60	0.67	0.73	0.77
Net Deferred Tax	-0.09	-0.11	-0.54	-0.62	-0.69	-0.73
Total Assets	9.69	9.78	9.78	11.02	12.14	13.80
Contingent Liabilities	0.04	0.04	0.04	7.31	5.57	4.02

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	0.01	0.01	0.01	0.02	0.02
Net Cash from Operating Activities	-0.87	-4.34	-0.93	-0.49	0.60
Net Cash Used In Investing Activities	-0.10	0.46	1.54	0.46	-0.21
Net Cash Used In Financing Activities	0.96	3.88	-0.61	0.03	-0.39
Net Inc./Dec In Cash And Cash Equivalents	-0.01	0.00	0.00	0.00	0.00
Cash And Cash Equivalents At End Of The Year	0.01	0.01	0.01	0.01	0.02

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

35.89%

FII Shareholding

0.00%

DII Shareholding

0.58%

Public Shareholding

63.53%

**Promoter pledged shareholding 35.89%

About MPS Pharmaa Ltd

MPS Pharmaa Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 6.13 crores. It has reported a sales of Rs. 0 crores and a net profit of Rs. -0.21 crores for the quarter ended December 2018. The company management includes , Peeyush Kumar Aggarwal,Pooja Chuni,Madhu Sharma,Ram Niwas Sharma,Ajay Sharma (MPS Pharmaa Ltd) among others.

Chairman

Registered office

138 Roz-Ka-Meo Industrial Area,Sohna,Mewat,Haryana,122103

FAX :

Background

Incorporation Year1994

Face Value₹10

Market Lot1

How to buy MPS Pharmaa shares on nse?

To buy MPS Pharmaa shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the MPS Pharmaa share price today?

The MPS Pharmaa shares price on nse is Rs.3.21 today.

What is the market cap of MPS Pharmaa shares on BSE ?

The company has a market capitalization of Rs.6.13Cr

What is the PE & PB ratio of MPS Pharmaa shares ?

PE is 0 and PB is 2.53

What is the 52 Week High and Low of MPS Pharmaa shares?

MPS Pharmaa stock price high: Rs.3.21 MPS Pharmaa stock price low: Rs.2.1